Document is current
Any future updates will be listed below
-
Authors
Keselman, Dennis J. https://orcid.org/0000-0003-3399-5043
Brandsema, John F. https://orcid.org/0000-0001-5945-3280
- License Information
-
More Information
Article History
Accepted: 1 April 2025
First Online: 15 April 2025
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Dennis J. Keselman declares that he has no potential conflicts of interest. John F. Brandsema is a consultant for Alexion, Audentes, AveXis/Novartis, Biogen, Cytokinetics, Dyne, Edgewise, Fibrogen, Genentech/Roche, Janssen, Marathon, Momenta, NS Pharma, PTC Therapeutics, Sarepta, Scholar Rock, Takeda, and WaVe. He is a speaker for AveXis and Biogen. He serves as a medical advisory council member for Cure SMA. He is a site investigator for clinical trials with Alexion, Astellas, AveXis/Novartis, Biogen, Catabasis, CSL Behring, Cytokinetics, Fibrogen, Genentech/Roche, Ionis, Lilly, Pfizer, PTC Therapeutics, Sarepta, Scholar Rock, Summit, and WaVe.
